BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10689717)

  • 21. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G
    Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children.
    Poutanen T; Tikanoja T; Riikonen P; Silvast A; Perkkiö M
    J Clin Oncol; 2003 Jun; 21(12):2349-56. PubMed ID: 12805337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dobutamine stress echocardiography identifies anthracycline cardiotoxicity.
    Cottin Y; L'huillier I; Casasnovas O; Geoffroy C; Caillot D; Zeller M; Solary E; Guy H; Wolf JE
    Eur J Echocardiogr; 2000 Sep; 1(3):180-3. PubMed ID: 11916591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclines.
    Ginsberg JP; Cnaan A; Zhao H; Clark BJ; Paridon SM; Chin AJ; Rychik J; Hogarty AN; Barber G; Rutkowski M; Kimball TR; DeLaat C; Steinherz LJ; Silber JH
    J Clin Oncol; 2004 Aug; 22(15):3149-55. PubMed ID: 15284267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise echocardiography reflects cumulative anthracycline exposure during childhood.
    Smibert E; Carlin JB; Vidmar S; Wilkinson LC; Newton M; Weintraub RG
    Pediatr Blood Cancer; 2004 Jun; 42(7):556-62. PubMed ID: 15127409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
    Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
    Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors.
    De Caro E; Smeraldi A; Trocchio G; Calevo M; Hanau G; Pongiglione G
    Pediatr Blood Cancer; 2011 Jan; 56(1):122-6. PubMed ID: 21058389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: a 5-year review at a single pediatric oncology center.
    Watts RG; George M; Johnson WH
    Cancer; 2012 Apr; 118(7):1919-24. PubMed ID: 21882180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.
    Elbl L; Hrstkova H; Tomaskova I; Blazek B; Michalek J
    Eur J Pediatr; 2005 Nov; 164(11):678-84. PubMed ID: 16044276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.
    Lewis AB; Crouse VL; Evans W; Takahashi M; Siegel SE
    Pediatrics; 1981 Jul; 68(1):67-72. PubMed ID: 6941210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.
    Sung RY; Huang GY; Shing MK; Oppenheimer SJ; Li CK; Li CK; Lau J; Yuen MP
    Int J Cardiol; 1997 Aug; 60(3):239-48. PubMed ID: 9261634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serial determination of anthracycline poisoning in children].
    Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H
    Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased arterial stiffness in children treated with anthracyclines for malignant disease.
    Herceg-Cavrak V; Ahel V; Batinica M; Matec L; Kardos D
    Coll Antropol; 2011 Jun; 35(2):389-95. PubMed ID: 21755708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
    Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
    J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of a Novel Handheld Wireless Platform for Detection of Cardiac Dysfunction in Anthracycline-Exposed Survivors of Childhood Cancer.
    Armenian SH; Rinderknecht D; Au K; Lindenfeld L; Mills G; Siyahian A; Herrera C; Wilson K; Venkataraman K; Mascarenhas K; Tavallali P; Razavi M; Pahlevan N; Detterich J; Bhatia S; Gharib M
    Clin Cancer Res; 2018 Jul; 24(13):3119-3125. PubMed ID: 29929955
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early and late anthracycline-induced cardiotoxicity in childhood: non-invasive evaluation of contractility in 116 patients].
    Agnoletti G; Bonazza A; Pennacchio M; Porta F; Arrighini A
    G Ital Cardiol; 1995 Oct; 25(10):1295-305. PubMed ID: 8682225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia.
    Rathe M; Carlsen NL; Oxhøj H; Nielsen G
    Pediatr Blood Cancer; 2010 Mar; 54(3):444-8. PubMed ID: 19830828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.